IBEC’s Nanoscale Bioelectrical Characterization group, headed by Gabriel Gomila, is a partner in a new EU-funded collaborative project set to develop a new tool for non-destructive 3D nanoscale structural characterization, the Volumetric Scanning Microwave Microscope (VSMM).
In their bulletin for February, the Spanish Association of Biotechnology Companies (ASEBIO) published an editorial by the president of their scientific committee Emilio Muñoz, about the impact of bionanotechnology in Spain and guidelines for the future.
Investigadores del IBEC han dado un gran salto hacia la comprensión de la segunda enfermedad degenerativa más común, la enfermedad de Parkinson, que afecta aproximadamente al 5% de la población al alcanzar los 85 años.
Todos hemos hecho comidas pesadas o consumido alimentos grasos y hecho la broma de que podemos notar cómo ‘se nos endurecen las arterias’. Aún así, la realidad de la ateroesclerosis – cuando la grasa, el colesterol y otras sustancias se acumulan en las paredes arteriales y forman estructuras sólidas llamadas placas – no es ninguna broma. Las consecuencias de esta enfermedad pueden incluir infartos y afecciones en las arterias coronarias, la principal causa de muerte en muchos países desarrollados.
IBEC’s Robotics group leader Alícia Casals is the subject of the February 2012 edition of Destacamus, a bimonthly magazine published by Biopol’H which profiles researchers.
En el marco de la iniciativa ESCOLAB, organizada por el Ayuntamiento de Barcelona, el miércoles recibimos la visita de los estudiantes de 3º de ESO de la escuela Oak House School en Barcelona.
IBEC director and head of the Biomaterials for Regenerative Therapies group Josep Planell was quoted as an expert opinion last week in an article in La Vanguardia. The story covered a new chip developed at MIT able to release drugs under the skin while dosage and timing is controlled wirelessly.
This week’s 5th Annual Conference of the Biomedical Research Technology Platforms in Barcelona, which IBEC is attending in its capacity as coordinator of the Spanish Nanomedicine Platform (NanoMed Spain), is the subject of an article in Spanish healthcare magazine Redacción Médica today.
The two IBEC-led CIBER-BBN tissue regeneration projects that were earmarked for funding by the EU’s ERA-NET EuroNanoMed initiative last year (see www.ibecbarcelona.eu/IBEC-News/funding-success-for-two-ibec-projects.html) have both received the national support they need to get started.
IBEC director Josep Planell’s research group has changed its name and is now known as the Biomaterials for Regenerative Therapies group.